WHEN TO RECOMMEND aortic valve replacement for mildly symptomatic or asymptomatic patients with moderate-to-severe aortic regurgitation is a difficult clinical problem. Severe chronic aortic regurgitation is associated with a generally favorable prognosis.1' 2 Approximately 75% of the patients are alive 5 years and 50% 10 years after the diagnosis.2 However, when symptoms develop, the patient's condition often deteriorates rapidly. Without surgery, the patient usually dies within 5 years after the onset of angina and 2 years after developing heart failure. In this issue of Circulation, Henry and associates report the results of serial M-mode echocardiographic studies in 50 consecutive symptomatic patients who underwent aortic valve replacement for isolated, moderate-to-severe aortic regurgitation.10' 11 In these studies, several echocardiographic indices were predictive of late death due to congestive heart failure in symptomatic patients who underwent otherwise successful aortic valve replacement. Specifically, a preoperative LV end-systolic dimension (ESD) of > 55 mm and percent fractional dimension shortening (%,AD) < 25% indicated an increased incidence of perioperative morbidity and late postoperative congestive heart failure and death compared with patients with similar symptoms but less depressed LV systolic function. A combination of the two findings (ESD > 55 mm and %zAD < 25%) was the most powerful predictor; 11 of 13 patients (85%) with these findings either died (nine patients) or had evidence of severe congestive heart failure postoperatively. Five of the nine deaths occurred in the immediate postoperative period. This high perioperative mortality risk may not be applicable to patients currently undergoing aortic valve replacement, owing to newer operative techniques for preserving myocardial function.
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The data of Henry and associates are consistent with the LV cineangiographic studies by Borow and co-workers,8 who found that the immediate and longterm results of aortic valve replacement were poor in the patients in whom the LV end-systolic volume index was markedly elevated (> 90 ml/m2). In the latter study the preoperative LV ejection fraction was of less predictive value. In contrast, Clark and associates reported no perioperative mortality in 17 patients with symptomatic aortic regurgitation and impaired LV performance.9 Also, they found no difference in late mortality in patients with a preoperative cineangiographic end-systolic volume of > 110 ml/m2 compared with those who had a smaller end-systolic volume. However, the 5-year survival in patients with an ejection fraction of < 45% was 33 ± 19%, compared with 94 ± 6% (p < 0.001) in those with an ejection fraction > 45%. However, not all patients with preoperative impairment of LV performance do poorly after aortic valve replacement; late postoperative LV systolic function improves in as many as 50% of the patients.5-9
Henry and co-workers also reported serial M-mode echocardiographic data in 37 initially asymptomatic patients with aortic regurgitation, 14 These two studies by Henry and associates provide interesting information concerning a common clinical problem. However, a note of caution is necessary for cardiologists planning to use these results to decide the time for aortic valve replacement in their own patients with moderate-to-severe aortic regurgitation. First, M-mode echocardiography is an excellent technique for defining LV minor-axis dimensions and percent shortening. This technique generally correlates well with biplane cineangiography for measuring LV dimensions and ejection phase indices in patients with normal-size left ventricles or mild-to-moderate LV dilatation.'2 14 However, in patients with marked LV volume overload, as occurs with severe aortic regurgitation, there is marked dilatation of the ventricle, and M-mode echocardiography tends to underestimate end-diastolic and end-systolic dimensions and overestimate ejection phase indices.'5 16 In patients with a large left ventricle, changes in the patient's position and alterations in transducer angulation may cause errors in measurements of LV dimensions of as much as 20%.'7 (Shah PM: personal communication). Therefore, M-mode echocardiography often inaccurately estimates LV performance in patients with severe aortic regurgitation, even in the absence of coincident ischemic heart disease and segmental wall motion abnormalities.
Second, as discussed by Henry and co-workers, echocardiographic assessment of global LV systolic function after operation is subject to considerable error because of abnormal septal motion, which occurs in approximately 90% of patients after aortic valve replacement.'" Measurements of LV ESD and %WD are highly inaccurate in this situation and should not be used to assess total LV performance. '9 Therefore, the serial postoperative echocardiographic data included in their two studies may not adequately reflect changes in LV systolic function. Since no angiographic data are given before and after surgery, we do not know whether or not some of the patients with impaired preoperative LV performance improved after aortic valve replacement.
Finally, measurements of LV end-diastolic and endsystolic dimensions and %,AD are only as good as the echocardiograms from which they are measured. Unless high-quality LV echocardiograms are obtained, they should not be used to assess LV dimensions or function in any patients, including those with chronic aortic regurgitation.
The M-mode echocardiographic serial studies reported by Henry and associates in patients with moderate-to-severe aortic regurgitation are of some interest to the clinical cardiologist. Their observations in symptomatic patients who undergo aortic valve replacement further support early operation in patients with symptoms of congestive heart failure or myocardial ischemia caused by chronic aortic regurgitation. This study, like others, indicates that symptomatic patients with markedly depressed LV systolic function before aortic valve replacement have a higher incidence of congestive heart failure and death in the late postoperative period.
Their echocardiographic data in initially asymptomatic patients who underwent serial studies are also noteworthy but less conclusive. Validation of these results in a large number of patients is necessary before other physicians can recommend aortic valve replacement for all asymptomatic patients with chronic aortic regurgitation and an LV ESD > 55 mm. Only five patients had ESD > 55 mm at the initiation of serial follow-up. Four of these patients were recommended for aortic valve replacement on the basis of congestive heart failure symptoms. Whether a similar percentage of a larger number of asymptomatic patients with aortic regurgitation and ESD > 55 mm would develop symptoms during a similar period of follow-up remains to be proved. We do not know whether such asymptomatic patients will have a poor short-or long-term prognosis after valve replacement compared with patients who have smaller ESDs.
In the future, other noninvasive techniques may be useful for defining patients with asymptomatic chronic aortic regurgitation who are candidates for early aortic valve replacement. Recent data indicate that most symptomatic patients with severe aortic regurgitation have a subnormal increment or reduction in LV ejection fraction during exercise as measured by radionuclide angiography.20 Whether or not the ability to identify LV dysfunction during exercise should influence the decision of when to operate in asymptomatic patients with severe aortic regurgitation is unknown. Additional radionuclide techniques recently have been introduced for the noninvasive quantitation of the aortic regurgitant fraction and may be useful for the serial assessment of such patients.2" 22 Available data indicate that patients with moderateto-severe aortic regurgitation resulting in symptoms of congestive heart failure or ischemia should undergo aortic valve replacement. If occlusive coronary artery 494 CIRCULATION EDITORIAL -VALVE REPLACEMENT/O'Rourke and Crawford disease is present, particularly in patients with symptoms of myocardial ischemia, coronary artery bypass grafting is indicated at the same operation.23 In symptomatic patients, both short-and long-term prognosis appears better when LV performance is normal or only mildly impaired, but operation is feasible in patients with severely impaired LV function because some improvement in LV performance can be expected in as many as 50% of the patients. 5 9 There are increasing data to support early operation in asymptomatic patients with severe aortic regurgitation and LV dysfunction in order to optimize surgical results. The echocardiographic studies of Henry and associates, despite the limitations of M-mode echocardiography, support these data. Aortic valve replacement seems reasonable in hospitals with < 5% perioperative mortality for asymptomatic patients with severe aortic regurgitation and impaired LV performance as quantitated by LV cineangiography (both decreased LV ejection fraction and increased endsystolic volume). However, each asymptomatic patient with severe aortic regurgitation must be assessed individually and there is no precise quantitative formula for making an unequivocal decision on who should undergo aortic valve replacement. Certainly, an LV ESD > 55 mm by M-mode echocardiography is not a proven criteria by which to make such decisions in asymptomatic patients.
